Hikma Pharmaceuticals PLC ADR (HKMPY)

31.0
+0.2(+0.65%)
  • Volume:
    1,288
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    30.5 - 32.1

HKMPY Overview

Prev. Close
30.8
Day's Range
30.5-32.1
Revenue
-
Open
32.1
52 wk Range
25.1-69.8
EPS
1.51
Volume
1,288
Market Cap
3.35B
Dividend (Yield)
1.06
(3.42%)
Average Volume (3m)
2,092
P/E Ratio
9.37
Beta
0.181
1-Year Change
-54.48%
Shares Outstanding
220,196,969
Next Earnings Date
-
What is your sentiment on Hikma Pharma ADR?
or
Market is currently closed. Voting is open during market hours.

Hikma Pharmaceuticals PLC ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Hikma Pharmaceuticals PLC ADR Analysis

Hikma Pharmaceuticals PLC ADR Company Profile

Hikma Pharmaceuticals PLC ADR Company Profile

Employees
8700

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing, marketing and selling of a broad range of generic, branded and in-licensed pharmaceuticals products in solid, semi-solid, liquid and injectable final dosage forms. The Company operates through three segments, such as Injectables, Generics and Branded. The Injectables business develops and manufactures generic injectable products, which are primarily used in hospitals. The Generics business develops and manufactures oral and other non-injectable generic products. The Branded business develops and manufactures branded generics and markets and sells in-licensed patented products in Middle East/North Africa (MENA). The Company’s products are sold in the retail and hospital markets. It also markets its products in Canada, which includes approximately 25 sterile injectable products, three in-licenced ophthalmic products and a pipeline of seven additional products.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyBuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryBuyStrong BuyStrong BuyBuyStrong Sell
  • Thanks you HKMPY. bullish move forward
    0